Diabetes mellitus
Conditions
Interventions
100 diabetic people perform aerobic exercise lasting 30 minutes and moderate intensity on the treadmill with 1 minute at 60% and 1 minute at 40% of the estimated maximum intensity.
30-minute, moderat
Other
E02.760.169.063.500.387.875
Sponsors
Universidade Federal do Vale do São Francisco
Universidade Federal do Vale do São Francisco
Eligibility
Age
10 Years to 90 Years
Inclusion criteria
Inclusion criteria: Will be included female and male volunteers over 10 years until 90 years and who do not have medical restriction to exercise or any kind of secondary diseases that may be aggravated due to research participation (secondary diseases already diagnosed by the doctor responsible for each diabetic (eg, peripheral and or central vasculopathies, retinopais and amputations).
Exclusion criteria
Exclusion criteria: Those who do not finish the sessions (acute), begin the practice of physical exercises during acute and chronic designs, or suffer any type of osteo-articular injury that prevents the practice of physical exercises or at the request of the doctor responsible for the exercise. each diabetic outside the scope of the research. In the chronic phase, volunteers who do not participate in at least 50% of the sessions will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to verify the improvement in glycated hemoglobin assessed by laboratorial blood analysis with improvement of at least 1%. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to verify improvements of at least 5% in scientropometry, body mass, BMI, WHR, skin folds and DEXA identifying muscle mass, fat and bone density. Evaluated by indirect and direct kinanthropometric methods such as anthropometric tape, plicometer and DEXA.;It is expected to see improvements of at least 5% in the neuromotor capacities of Strength, Endurance and Flexibility assessed by standardized physical tests.;Reductions of at least 2% are expected in Cardiovascular Measurements such as Blood Pressure, Heart Rate, Heart Rate Variability and Double Product through cardiac monitor and automatic blood pressure.;Improvements of at least 2% are expected in Clinical Biochemical Measurements such as Fasting Glucose, Glycated Hemoglobin, LDL, HDL, VLDL, Total Cholesterol, Triglyceride, C-Reactive Protein, CBC, Insulin, Microalbuminuria and Creatinine assessed by laboratorial blood analysis ;Improvements of at least 2% are expected in Metabolics variables, Oxygen Consumption, Metabolic Equivalent, Energy Expenditure and Capillary Blood Glucose using estimation formulas, metabolic gas analyzer and capillary glucometer. | — |
Countries
Brazil
Contacts
Public ContactJorge Gomes
Universidade de Pernambuco
Outcome results
None listed